睿视科技完成数千万元A2轮融资，引领近视防控行业革新

Core Viewpoint - The article highlights the innovative approach of Shanghai Ruisi Health Technology Co., Ltd. in integrating eye care products into the daily lives of children and adolescents, focusing on the prevention and control of myopia through advanced technology and clinical validation [3][12]. Company Overview - Ruisi Technology was established in 2017 and has developed AI-based optical brain nerve regulation technology, combining artificial intelligence, optical engineering, and clinical optometry to innovate in myopia management [3][5]. - The company has created a range of products, including the D1 vision training device and the Far Vision Light Screen PLUS 2.0, which utilize proprietary digital technology to provide personalized visual adjustments [5][8]. Clinical Validation - Multi-center clinical studies conducted by reputable institutions have shown that Ruisi's products significantly slow down the progression of myopia, with results indicating a 50% reduction in eye axis shortening and an 80% decrease in myopia degree in certain trials [8][9]. - The company has established a complete trust system from clinical data to academic certification, ensuring the long-term safety and effectiveness of its products [9]. Market Strategy and Future Plans - The recent funding will be directed towards two main areas: advancing medical qualifications through the registration of medical devices and enhancing technology and market reach [11]. - Ruisi aims to create a closed-loop service system that integrates detection, training, and feedback, targeting users aged 3 to 18 and expanding its presence across over 400 cities in China [11][12]. Industry Impact - Ruisi Technology plays a leading role in promoting industry standardization, having co-hosted the release of the first domestic standards for far vision technology, which aims to provide scientific backing for the industry [9][12]. - The company is positioned to address the high prevalence of myopia among children and adolescents in China, with significant social value and market potential [12].